Genetic and epigenetic fine mapping of causal autoimmune disease variants

Nature. 2015 Feb 19;518(7539):337-43. doi: 10.1038/nature13835. Epub 2014 Oct 29.

Abstract

Genome-wide association studies have identified loci underlying human diseases, but the causal nucleotide changes and mechanisms remain largely unknown. Here we developed a fine-mapping algorithm to identify candidate causal variants for 21 autoimmune diseases from genotyping data. We integrated these predictions with transcription and cis-regulatory element annotations, derived by mapping RNA and chromatin in primary immune cells, including resting and stimulated CD4(+) T-cell subsets, regulatory T cells, CD8(+) T cells, B cells, and monocytes. We find that ∼90% of causal variants are non-coding, with ∼60% mapping to immune-cell enhancers, many of which gain histone acetylation and transcribe enhancer-associated RNA upon immune stimulation. Causal variants tend to occur near binding sites for master regulators of immune differentiation and stimulus-dependent gene activation, but only 10-20% directly alter recognizable transcription factor binding motifs. Rather, most non-coding risk variants, including those that alter gene expression, affect non-canonical sequence determinants not well-explained by current gene regulatory models.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autoimmune Diseases / genetics*
  • Autoimmune Diseases / immunology
  • Autoimmune Diseases / pathology
  • Base Sequence
  • Chromatin / genetics
  • Consensus Sequence / genetics
  • Enhancer Elements, Genetic / genetics
  • Epigenesis, Genetic / genetics*
  • Epigenomics
  • Genome-Wide Association Study
  • Humans
  • Nucleotide Motifs
  • Organ Specificity
  • Polymorphism, Single Nucleotide / genetics*
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism
  • Transcription Factors / metabolism

Substances

  • Chromatin
  • Transcription Factors